Company intelligence / Profile preview

Verde Technologies

Minnetonka, Minnesota, United States

Ownership: Private
Development stage: Other

Overview

Developer of Deterra Drug Deactivation System using patented MAT12 Molecular Adsorption Technology to render unused pharmaceuticals inert for safe disposal, reducing drug misuse and environmental impact.

Industry: Non-Drug Biotech

Partnerships

Community Anti-Drug Coalitions of America (CADCA)DEA Educational FoundationMothers Against Prescription Drug Abuse (MAPDA)National Hospice and Palliative Care Organization (NHPCO)

Beyond the preview

Go deeper on Verde Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Verde Technologies.

Explore the full profile